Validation Data Gallery
Tested Applications
Recommended dilution
| Application | Dilution |
|---|---|
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Product Information
68273-1-PBS targets SCN5A in Indirect ELISA, IHC, WB applications and shows reactivity with rabbit, rat, mouse, human samples.
| Tested Reactivity | rabbit, rat, mouse, human |
| Host / Isotype | Mouse / IgG1 |
| Class | Monoclonal |
| Type | Antibody |
| Immunogen | SCN5A fusion protein Ag19275 相同性解析による交差性が予測される生物種 |
| Full Name | sodium channel, voltage-gated, type V, alpha subunit |
| Calculated molecular weight | 2016 aa, 227 kDa |
| Observed molecular weight | 227 kDa |
| GenBank accession number | BC140813 |
| Gene Symbol | SCN5A |
| Gene ID (NCBI) | 6331 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Protein G purification |
| UNIPROT ID | Q14524 |
| Storage Buffer | PBS Only |
| Storage Conditions | Store at -80°C. |
Background Information
Voltage-gated sodium channels are responsible for initiation and propagation of action potentials in the membranes of neurons and most electrically excitable cells (PMID: 10798388). These channels are composed of a large alpha subunit that forms the ion conduction pore and auxiliary beta subunits (PMID: 11486343). The alpha subunits form a gene family with at least 10 members. Nav1.5, encoded by the SCN5A gene in humans, is a pore forming alpha subunit of voltage-gated sodium channels. Nav1.5 is the principal Na+ channel isoform expressed in cardiomyocytes. Mutations in SCN5A gene have been linked to many cardiac electrical disorders, including the congenital and acquired long QT syndrome, Brugada syndrome, conduction slowing, sick sinus syndrome, atrial fibrillation, and dilated cardiomyopathy (PMID: 23123192).